CN103788010B - 非布索坦中间体及其制备方法 - Google Patents
非布索坦中间体及其制备方法 Download PDFInfo
- Publication number
- CN103788010B CN103788010B CN201210431202.2A CN201210431202A CN103788010B CN 103788010 B CN103788010 B CN 103788010B CN 201210431202 A CN201210431202 A CN 201210431202A CN 103788010 B CN103788010 B CN 103788010B
- Authority
- CN
- China
- Prior art keywords
- reaction
- formula
- methods according
- febuxostat
- grignard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(N=C(*)*1)=C1*(OCC1=CC=CCC1)=O Chemical compound CC(N=C(*)*1)=C1*(OCC1=CC=CCC1)=O 0.000 description 2
- SFLMFHMYVDQCSF-UHFFFAOYSA-N CC(C)CCc1c(C=N)cc(C(C2)NC(C)=C2C(OCc2ccccc2)=O)cc1 Chemical compound CC(C)CCc1c(C=N)cc(C(C2)NC(C)=C2C(OCc2ccccc2)=O)cc1 SFLMFHMYVDQCSF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (28)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210431202.2A CN103788010B (zh) | 2012-11-01 | 2012-11-01 | 非布索坦中间体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210431202.2A CN103788010B (zh) | 2012-11-01 | 2012-11-01 | 非布索坦中间体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103788010A CN103788010A (zh) | 2014-05-14 |
CN103788010B true CN103788010B (zh) | 2015-11-25 |
Family
ID=50664118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210431202.2A Active CN103788010B (zh) | 2012-11-01 | 2012-11-01 | 非布索坦中间体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103788010B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106470981B (zh) * | 2014-06-23 | 2019-05-07 | 湘北威尔曼制药股份有限公司 | 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸的新型衍生物、其制备方法和应用 |
CN105218479B (zh) * | 2014-06-23 | 2019-10-25 | 湘北威尔曼制药股份有限公司 | 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸的新型衍生物、其制备方法和应用 |
CN107674040B (zh) * | 2017-10-26 | 2021-02-19 | 天津力生制药股份有限公司 | 一种非布司他杂质转化为非布司他的方法 |
CN110642804A (zh) * | 2019-10-17 | 2020-01-03 | 武汉光谷亚太医药研究院有限公司 | 一种非布司他的某个特定杂质的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011073617A1 (en) * | 2009-12-14 | 2011-06-23 | Cipla Limited | Processes for the preparation of febuxostat and salts thereof |
WO2011139886A2 (en) * | 2010-04-29 | 2011-11-10 | Dr. Reddy's Laboratories Ltd. | Preparation of febuxostat |
WO2012014117A1 (en) * | 2010-07-30 | 2012-02-02 | Ranbaxy Laboratories Limited | Improved process for the preparation of febuxostat |
-
2012
- 2012-11-01 CN CN201210431202.2A patent/CN103788010B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011073617A1 (en) * | 2009-12-14 | 2011-06-23 | Cipla Limited | Processes for the preparation of febuxostat and salts thereof |
WO2011139886A2 (en) * | 2010-04-29 | 2011-11-10 | Dr. Reddy's Laboratories Ltd. | Preparation of febuxostat |
WO2012014117A1 (en) * | 2010-07-30 | 2012-02-02 | Ranbaxy Laboratories Limited | Improved process for the preparation of febuxostat |
Non-Patent Citations (7)
Title |
---|
段行信.酰胺脱水.《实用精细有机合成手册》.化学工业出版社,2000,第183页. * |
荣国斌.卤代汀与金属的反应.《大学有机化学基础 上册》.华东理工大学出版社,2006,第276-279页. * |
荣国斌等.卤代汀与金属的反应.《大学基础有机化学》.化学工业出版社,2011,第170-172页. * |
荣国斌等.酰胺的脱水.《有机化学精析精练》.华东理工大学出版社,2004,第151页. * |
韩广甸等.格氏反应.《有机制备化学手册 中卷》.石油化学工业出版社,1977,第168-174页. * |
高职高专化学教材编写组.酰胺脱水反应.《有机化学》.高等教育出版社,2001,第265页. * |
鲁崇贤等.酰胺的脱水.《有机化学》.科学出版社,2003,第524页. * |
Also Published As
Publication number | Publication date |
---|---|
CN103788010A (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101798270B (zh) | 一种3-氨基-1-金刚烷醇的制备方法 | |
CN103709121B (zh) | 医药级2-硫醇基苯并噻唑及其衍生物dm的制备方法 | |
CN103788010B (zh) | 非布索坦中间体及其制备方法 | |
CN102584795A (zh) | 一种克里唑替尼的制备方法 | |
CN107501112A (zh) | 一种手性β‑氨基酸的手性合成方法及医药中间体的合成方法 | |
CN114213430A (zh) | 4-氨基噻吩[3,2-d]嘧啶-7-羧酸的制备方法、蛋白激酶抑制剂中间体 | |
CN114685485B (zh) | 一种吡啶并咪唑硫代丙酸抗痛风化合物的合成方法 | |
CN104744266B (zh) | 替格瑞洛中间体的制备方法 | |
CN106986886B (zh) | 一种4-氟-3-三氟甲氧基苯基硼酸频哪醇酯的制备方法 | |
CN102285937A (zh) | 非布索坦的合成方法 | |
CN102464661B (zh) | 一种5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸乙酯的制备方法 | |
CN103788011B (zh) | 一种非布索坦中间体及其制备方法 | |
CN114716382B (zh) | 一种抗新冠药物Ensitrelvir中间体的连续流合成工艺 | |
CN106810546A (zh) | 一种芜地溴铵化合物 | |
CN102336721B (zh) | 一种利用含水氨噻肟酸合成ae-活性酯的方法 | |
CN111116493B (zh) | 一种制备Apabetalone的方法、中间体及其中间体的制备方法 | |
CN103788012A (zh) | 一种制备非布索坦的方法 | |
CN104496900A (zh) | 一种2-甲氧基-6-酮-5,7,8-三氢-喹啉的制备方法 | |
CN100593538C (zh) | 一种n-取代丙烯酰基-2,5-吡咯二酮类化合物的制备方法 | |
CN101555248B (zh) | 一种多取代1,5-萘啶化合物的制备方法 | |
CN105085595A (zh) | 一种脱酰基保护合成2,6-位卤代嘌呤核苷的方法 | |
EP3026047A1 (en) | Method for producing heterocyclic compound | |
CN106279114B (zh) | 一种Taladegib的合成方法 | |
CN107602602A (zh) | 一种3‑氰基吡啶‑5‑硼酸频哪醇酯的合成方法 | |
CN103242244B (zh) | 一种卡奈替尼的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 100871, Beijing, Haidian District Cheng Fu Road 298, founder building, 9 floor Patentee after: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee after: PKU HEALTHCARE Corp.,Ltd. Patentee after: PKU HEALTHCARE INDUSTRY Group Address before: 100871, Beijing, Haidian District, Cheng Fu Road, No. 298, Zhongguancun Fangzheng building, 5 floor Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee before: SOUTHWEST SYNTHETIC PHARMACEUTICAL Corp.,Ltd. Patentee before: Pku Healthcare Industry Group Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221010 Address after: 3007, Hengqin international financial center building, No. 58, Huajin street, Hengqin new area, Zhuhai, Guangdong 519031 Patentee after: New founder holdings development Co.,Ltd. Patentee after: PKU HEALTHCARE Corp.,Ltd. Patentee after: Peking University Medical Management Co.,Ltd. Address before: 100871, Beijing, Haidian District Cheng Fu Road 298, founder building, 9 floor Patentee before: PEKING UNIVERSITY FOUNDER GROUP Co.,Ltd. Patentee before: PKU HEALTHCARE Corp.,Ltd. Patentee before: PKU HEALTHCARE INDUSTRY Group |
|
TR01 | Transfer of patent right |